Day 2 15.9.20
1:45 – 2:00 pm
(European time) Zoom teleconference opening
2:00 – 2:20 pm
9- Synthesis of day 1: PSC Chair (15 mn)
Discussion (5 mn)
2:20 – 3:40 pm
10- Pharmacology of anti-TB drugs & ART (40 mn) – High dose of rifampicin: field experience – M. Boeree (10 mn) – Interactions between rifampicin and efavirenz and dolutegravir – K. Dooley (10 mn) – Summary of chosen options in INTENSE TBM trial – F. Bonnet (10 mn) – Summary of proposed pharmacology analysis in DATURA – G. Peytavin (10 mn) Discussion (40 mn)
3:40 – 4:15 pm
11- Information sheets and consent form (15 mn) – Summary of proposed information sheets and consent form – C. Quillet (5 mn) – Comments from ethical expert – J.A. Singh (5 mn) – Comments from community expert – J. Gapiya Niyonzima (5 mn) Discussion (20 mn) Break 15 minutes
4:30 – 5:00 pm
12- Synthesis of the kick off meeting & next steps: PSC Chair, F.X. Blanc, D. Laureillard